Actively Recruiting
Adult Autoimmune Myopathies (MAIA): Clinical and Immunological Characterization, Constitution of a Patient Library
Led by University Hospital, Brest · Updated on 2025-02-05
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective study at a single center to follow adult patients suspected of having idiopathic inflammatory myopathy. The study aims to collect detailed clinical information over time and gather various biological samples to better understand these autoimmune muscle diseases. This research is led by the University Hospital, Brest. Participants will be part of an observational cohort focused on autoimmune myopathies. Biological samples collected include blood, urine, stool, and muscle tissue specimens. The study includes regular assessments, with a key measurement at 6 months to analyze different types of lymphocytes (B cells, T cells, and TH-17 cells) in the blood to explore immune system changes. During the study, participants will provide clinical data and biological samples at scheduled visits. The research team will monitor immune cell distribution as the primary outcome. Participation involves ongoing clinical evaluation and sample collection, with no masking or placebo use. The study started in May 2022 and will continue through May 2030, allowing long-term observation of disease characteristics and immune responses.
CONDITIONS
Brief Title
Adult Autoimmune Myopathies (MAIA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical suspicion of Adult Inflammatory Myopathy
- Social security affiliation
- Age 18 years or older
You will not qualify if you...
- Pregnant and lactating women
- Patients unable to consent
- Patients refusing to participate in the research
- Patients under legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 months
Participants undergo diagnostic evaluation to characterize adult autoimmune myopathies.
Trial Site Locations
Total: 1 location
1
CHU de BREST
Brest, France, 29200
Actively Recruiting
Research Team
D
Dewi GUELLEC
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here